These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 22447482)
1. Recruitment of pulmonary hypertension patients for PATENT trial with Riociguat [corrected] completed Sub-Saharan pulmonary hypertension study launched. Aalbers J Cardiovasc J Afr; 2012 Mar; 23(2):120. PubMed ID: 22447482 [No Abstract] [Full Text] [Related]
2. Riociguat recommended by CHMP for approval in the EU for use in two forms of pulmonary hypertension. Dowdall M Future Cardiol; 2014 Mar; 10(2):163. PubMed ID: 24883440 [No Abstract] [Full Text] [Related]
3. New insights into pulmonary hypertension. Furlow B Lancet Respir Med; 2013 Sep; 1(7):508. PubMed ID: 24461605 [No Abstract] [Full Text] [Related]
4. [Riociguat - a stimulator of soluble guanylate cyclase: a new mode of action helps patients with pulmonary hypertension]. Kreutzkamp B Med Monatsschr Pharm; 2013 Dec; 36(12):442-7. PubMed ID: 24450268 [No Abstract] [Full Text] [Related]
5. Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2). Rubin LJ; Galiè N; Grimminger F; Grünig E; Humbert M; Jing ZC; Keogh A; Langleben D; Fritsch A; Menezes F; Davie N; Ghofrani HA Eur Respir J; 2015 May; 45(5):1303-13. PubMed ID: 25614164 [TBL] [Abstract][Full Text] [Related]
6. Riociguat for the treatment of pulmonary hypertension. Hambly N; Granton J Expert Rev Respir Med; 2015; 9(6):679-95. PubMed ID: 26599488 [TBL] [Abstract][Full Text] [Related]
7. Riociguat: a novel therapeutic option for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Mielniczuk LM; Swiston JR; Mehta S Can J Cardiol; 2014 Oct; 30(10):1233-40. PubMed ID: 25154043 [TBL] [Abstract][Full Text] [Related]
8. [Pulmonary arterial hypertension--a rare form of pulmonary hypertension]. Schenk M Dtsch Med Wochenschr; 2010 May; 135(21):p21. PubMed ID: 20509110 [No Abstract] [Full Text] [Related]
9. Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2. Humbert M; Coghlan JG; Ghofrani HA; Grimminger F; He JG; Riemekasten G; Vizza CD; Boeckenhoff A; Meier C; de Oliveira Pena J; Denton CP Ann Rheum Dis; 2017 Feb; 76(2):422-426. PubMed ID: 27457511 [TBL] [Abstract][Full Text] [Related]
10. Riociguat, an oral soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension. Belik J Curr Opin Investig Drugs; 2009 Sep; 10(9):971-9. PubMed ID: 19705340 [TBL] [Abstract][Full Text] [Related]